Evidence map›Paper›PMID 16620391›Full record

ArticleBMC cancer2006

Breast tumor copy number aberration phenotypes and genomic instability.

Jane Fridlyand, Antoine M Snijders, Bauke Ylstra, Hua Li, Adam Olshen, Richard Segraves, Shanaz Dairkee, Taku Tokuyasu, Britt Marie Ljung, Ajay N Jain and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 1 pooled it
22.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 1 synthesis or guideline pooled it, 294 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Jane FridlyandDepartment of Epidemiology and Biostatistics, University of California San Francisco, CA 94143, USA. fridlyand@cc.ucsf.edu
Antoine M Snijders
Bauke Ylstra
Hua Li
Adam Olshen
Richard Segraves
Shanaz Dairkee
Taku Tokuyasu
Britt Marie Ljung
Ajay N Jain
Jane McLennan
John Ziegler
Koei Chin
Sandy Devries
Heidi Feiler
Joe W Gray
Frederic Waldman
Daniel Pinkel
Donna G Albertson
UCSF Helen Diller Family Comprehensive Cancer Center · USUniversity of California, San Francisco · USCancer Research Institute · USLawrence Berkeley National Laboratory · US

Funding

Tissue and Outcomes CoreP50CA058207 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRAY, JOE W. · 1992 to 2012
$32.7M
Genomic Analysis of ER Negative Breast CancerR01CA101359 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALBERTSON, DONNA G. · 2003 to 2007
$1.9M
High Resolution Genomic Analysis of Amplicon StructureR01CA090421 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALBERTSON, DONNA G. · 2003 to 2007
$1.0M
NCI NIH HHS CA101359NCI NIH HHS CA58207NCI NIH HHS CA78913NCI NIH HHS CA90421NCI NIH HHS P50 CA058207NCI NIH HHS R01 CA090421NCI NIH HHS R01 CA101359
6 · The paper itself

Abstract

backgroundGenomic DNA copy number aberrations are frequent in solid tumors, although the underlying causes of chromosomal instability in tumors remain obscure. Genes likely to have genomic instability phenotypes when mutated (e.g. those involved in mitosis, replication, repair, and telomeres) are rarely mutated in chromosomally unstable sporadic tumors, even though such mutations are associated with some heritable cancer prone syndromes.

methodsWe applied array comparative genomic hybridization (CGH) to the analysis of breast tumors. The variation in the levels of genomic instability amongst tumors prompted us to investigate whether alterations in processes/genes involved in maintenance and/or manipulation of the genome were associated with particular types of genomic instability.

resultsWe discriminated three breast tumor subtypes based on genomic DNA copy number alterations. The subtypes varied with respect to level of genomic instability. We find that shorter telomeres and altered telomere related gene expression are associated with amplification, implicating telomere attrition as a promoter of this type of aberration in breast cancer. On the other hand, the numbers of chromosomal alterations, particularly low level changes, are associated with altered expression of genes in other functional classes (mitosis, cell cycle, DNA replication and repair). Further, although loss of function instability phenotypes have been demonstrated for many of the genes in model systems, we observed enhanced expression of most genes in tumors, indicating that over expression, rather than deficiency underlies instability.

conclusionMany of the genes associated with higher frequency of copy number aberrations are direct targets of E2F, supporting the hypothesis that deregulation of the Rb pathway is a major contributor to chromosomal instability in breast tumors. These observations are consistent with failure to find mutations in sporadic tumors in genes that have roles in maintenance or manipulation of the genome.

Indexed as

Chromosome AberrationsGene DosageGenomic InstabilityAdultAgedBreast NeoplasmsCarcinoma, Ductal, BreastChromosomes, HumanDNA, NeoplasmE2F Transcription FactorsFemaleGene Expression Regulation, NeoplasticGenes, p53Genes, RetinoblastomaHumansKaryotypingDNA, NeoplasmE2F Transcription FactorsNeoplasm ProteinsRetinoblastoma Protein

Identifiers

PMID16620391
PMCPMC1459181
OpenAlexW2110359348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.